Clinical Trials Directory

Trials / Terminated

TerminatedNCT02632292

EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Luebeck · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Prospective, randomized, controlled, multicenter, open-label study to compare everolimus-eluting bioresorbable vascular scaffolds to everolimus-eluting stents in patients with diabetes mellitus.

Conditions

Interventions

TypeNameDescription
DEVICEAbsorb GT1Bioresorbable vascular scaffold
DEVICEPromusEverolimus-eluting stent

Timeline

Start date
2016-01-01
Primary completion
2017-01-03
Completion
2017-01-03
First posted
2015-12-16
Last updated
2019-09-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02632292. Inclusion in this directory is not an endorsement.